人类单纯性先天性心脏病中TBX5基因的突变及表达研究

本文首次较为完整地报道了藏汉通婚子代群体的14项肤纹参数（其中藏父汉思及汉父藏母各100 例）,并将这些肤纹参数分别与其藏汉父母样本的有关肤纹参数进行比较,再与1000例藏族及1040例 汉族两个大样本的有关肤纹参数进行比较。结果表明：藏汉后代的肤纹特征介于藏族和汉族之间,提示 肤纹参数的多因子遗传本质。     

APC基因结构及功能异常与人类肿瘤的关系

腺瘤样结肠息肉病易感基因是１９９１年从结肠癌中克隆到的一个新的抑癌基因,定位于５号染色体长臂。ＡＰＣ基因产物功能不茂清楚,发现其可调节ｃ－ｍｙｃ基因ｍＲＮＡ的成熟和ｒａｓ基因的表达,与蛋白质相互作用有关。     

猪GH基因部分突变位点对生产性能的影响

本试验利用PCR-RFLPs技术,用MspⅠ,ApaⅠ两种限制酶,检测了猪生长激素基因+206～+711位共506bp片段中的[+295～+300、+563～+566]2处突变位点,分析了各多态位点在姜曲海猪中的分布及其与生产性能的关系.发现:姜曲海猪中,MspⅠ酶切突变位点中的G1G2基因型和G2G2基因型个体的生产性能没有差异,不同日龄体重在两组间变化没有规律.ApaⅠ酶切突变位点G4G4基因型个体的20日龄体重、45日龄体重高于G3G3/G3G4基因型个体,但差异不显著,G4G4基因型个体的70日龄体重极显著高于G3G3/G3G4基因型个体(P<0.01).G4G4基因型个体的0～70日龄日增重也极显著高于G3G3/G3G4基因型个体(P<0.01).这些结果显示GH基因有可能作为数量性状基因座的侯选基因。 Abstract:A 506bp segment of the porcine growth hormone gene encompassing base +206 of the first intro through base +711 of the third exon was amplified by PCR [Base numbering followed the designation of Vice & Wells (1987)].Two polymorphic restriction sites forApaI,Msp[ were identified at +295~+300,+563~+566 respectively.DNA was from Jianquhai breeds.The effect of genotype on bodyweight was analysed.The result showed that there was no difference of bodyweight between G1G2 and G2G2 genotype pigs in MspI polymorphic restriction sites.But in Apa I polymorphic restriction sites,the 70-days-bodyweight and average day gain from birth to 70-days of G4G4 genotype pigs was extremely significant(P<0.01) higher than G3G4/G3G3 genotype pigs.Result suggested that GH gene may be a candidate gene for quantitative trait locus in pigs.     

基因体外随机突变的两种方法的研究

引导蛋白质功能进化常用的方法是模拟和加速蛋白质基因自然重组的进程,即在蛋白质的基因中引进随机突变。因此,蛋白质基因体外随机突变的方法影响着引导蛋白质功能进化的效果。本文描述两种简单而有效的基因体外随机突变发生方法。一种是化学诱变法：将蛋白质基因用1.0mol/L硝酸钠在室温下处理1h,然后将突变基因插入质粒,导入大肠杆菌中表达;另一种方法是延伸诱变法：将10个随机氨基酸短肽基因连接到蛋白质基因上,使蛋白质C末端连接随机短肽,通过增大蛋白质分子来达到延伸蛋白质序列空间的目的。来自嗜热脂肪芽孢杆菌的过氧化氢酶I基因用这两种方法进行了随机突变,获得了大量突变体酶基因。通过对突变体酶基因表达产物性质变化的测定,证明这两种基因诱变方法能够有效地诱发基因的随机突变。 Abstract:Two novel and simple methods were described in the paper for in vitro mutagenesis and recombinatin of polynucleotide sequence to mimic and accelerate nature's recombination strategy to direct the evolution of protein function.One is chemical mutagenesis: protein gene was inserted into M13mp18,and the single－stranded DNA was treated with 1．0mol/L sodium nitrite at room temperature for 1h for mutation and converted into duplex,then the mutated gene was ligated to plasmid for expression.Another is elongation mutagenesis: random peptide of 10 amino acid was connected at C－terminal of protein to expand the sequence space by increasing proteins dimensions,then the elongation mutated gene expressed in E.coli.We have used these two methods to recombine the thermostabilized catalase I, and these two methods were found to be efficient to form a lot of catalase I mutates by identifying the properties of mutated enzyme.     

“基因”一词的由来

1909年,约翰森创造“基因”(gene)一词作为遗传单位的名称。该词是由德?弗里斯创造的“泛生子”(pangene)一词缩短而成的,而“泛生子”一词则衍生于达尔文提出的“泛生论”(theory of pangenesis)。约翰森的这一创造堪称“推陈出新”的典范。 Abstract: In1909,Johannsen coined the word “gene”, shortened from the pangene of de Vries and ultimately derived from Darwin’s word pangenesis,to denote the unit of heredity.It was an outstanding example of“weeding through the old to bring forth the new ”.     

转基因植物中筛选标记基因的利用及消除

在基因转移过程中,人们常常使用标记基因来筛选转化细胞或组织。常用的筛选标记基因尤其是抗生素抗性基因的使用往往对环境及植物体的生长发育产生不良影响,且影响基因多重转化。为了消除这些弊端,一种全新的发展策略即获取无选择标记的转基因植物应运而生。本文主要综述转基因植物中有关筛选标记基因及其消除方法。 Abstract:Selective marker gene is usually used to select transformed cells or tissue during gene transfer.However,the use of selective marker gene,especially antibiotic-resistant gene,is harmful to environment,plant development and affects multi-transformation.A new strategy that offers a approach for the elimination of those disadvantages caused by the selectable marker gene is developed.We summarized correlative marker genes used in transgenic plants and some methods of its removal.     

植物防御系统中抗病相关基因的研究进展

本文论述了植物防御系统中抗病相关基因（resistance gene,R基因）的研究进展。列表总结了迄今已克隆的R基因,并将其归为四种不同的类型。综述了不同基因表达产物-R蛋白在细胞中的定位及其相应的功能。此外,还对R基因编码区的多态性、R基因在染色体上排列方式以及R基因的进化与起源等问题进行了讨论。 Abstract:This review comments on recent advances in research of disease resistance genes(R Genes) in defence system of plants.The R genes cloned up to date are summarized and classified roughly into four classes listed in the Table 1.The location and the founction of the R proteins,i.e.,the expressed products of different R genes in the cells are reviewed.In addition,the polymophism of coding region of R genes,the different fashions of R gene arrangement on the chromosomes,and the evolution and origin of R genes are discussed.     

人胰岛素基因在体内外表达的研究

利用定点突变人胰岛素基因,以脂质体载体和质粒不同比例形成的复合物进行体内外转染。体外转染鼠肝细胞,G418进行筛选,利用放免法测定培养液中胰岛素含量;体内通过肝门脉注射,测定模型鼠血糖及转染后7天时血液中胰岛素的含量,结果显示目的基因已转入肝细胞,且体内外转染都有一定量的成熟胰岛素表达,体外转染中质粒与脂质体比为1∶6转染后24h表达量最高为10.45μIU/ml,体内转染使模型鼠的糖尿病症状明显改善,血糖最高降幅达55%。 Abstract:The transfection of mutated human insulin gene was studied using the complex of different proportion of plasmid and Liposome.Hepatic cell was used as the target cell in vitro,isolation of Hepatic cell including insulin gene was carried out by G418,the expression level of insulin in medium was measured by RIA method.The portal vein was cannulated with therapeutic gene in vivo,the blood glucose of the model was regularly examined and the insulin level was detected on the seventh day after transfection.The results showed that the target gene was transferred into the hepatic cell,expression of mature insulin was detected both in vivo and in vitro,It reached the peak 10.45μIU/ml on the 24th hour after transfection with the proportion 1:6 of.plasmid and Liposome in hepatic cell.Diabetic sympotom of the model was improved after transgene,the blood glucose could decrease 55% at the most.     

拟南芥SUPERMAN基因表观突变的研究进展

本文综述了拟南芥SUPERMAN基因表观突变体clark kent（clk）的表型、基因型、DNA甲基化及表观突变机制等方面的研究进展。主要研究结果有：clk是SUPERMAN(SUP)的等位基因,能遗传但不稳定,其对称位点（CpG和CPXPG）和非对称位点的胞嘧啶高度甲基化,伴随着SUP转录水平的下降;CpG和CPXPG胞嘧啶甲基转移酶分别是METHYLTRANSFERASE1（MET1）和受KRYPTONITE基因调控的CHROMOMETHYLASE3 (CMT3)。 Abstract:The SUPERMAN gene in Arabidopsis has its epigenetic mutants (the clark kent alleles,clk). The phenotype of clk and its genotype and methylated patterns and the epi-mutation mechanisms of SUPERMAN were summarized in the review. Heritable but unstable sup epi-alleles are associated with nearly identical patterns of excess cytosine methylation within the SUP gene and a decreased level of SUP RNA. The methylation of cytosine at CpG and CPXPG is controlled by METHYLTRANSFERASE1（MET1）and CHROMOMETHYLASE3 (CMT3) which is regulated by KRYPTONITE gene,respectively.     

应用蛋白截短技术检测APC基因胚系突变

建立蛋白截短检测技术,分析家族性腺瘤样息肉病（FAP）发病相关基因APC基因的胚系突变,研究基因突变型与FAP疾病表型的关系。经临床诊断的22例FAP患者及43例散发性大肠癌患者,分别取外周静脉血和正常结肠粘膜组织,常规提取基因组DNA。应用蛋白截短检测技术,分段分析APC基因巨大的第15外显子,对检出截短蛋白的样本进行测序,以确定突变位点及突变性质。22例FAP患者中,5例患者存在APC基因第15外显子的胚系突变,均为碱基缺失造成的移码突变,导致截短蛋白的产生;43例散发性大肠癌患者中未检测到APC基因第15外显子的胚系突变。蛋白截短检测技术是一种高效的基因突变分析技术,适用于大片段基因（如APC基因第15外显子）截短型突变的检测,可作为FAP症状出现前的常规基因诊断技术的一项有效补充。     

胃癌的基因治疗进展

基因治疗是近年来治疗肿瘤的新方法,因治疗策略的不同而发展为2个分支:一是分子肿瘤治疗,包括肿瘤抑制基因治疗、自杀基因治疗、反义基因治疗、抑制肿瘤血管形成的治疗、免疫基因治疗;二是virotherapy。简要综述了肿瘤基因治疗的各种方法及其在胃癌治疗中的应用和发展前景。     

胃癌发展相关阶段中E-cadherin基因启动子甲基化及蛋白表达的研究

为了研究E cadherin基因启动子甲基化在胃癌发生及发展阶段中的作用 ,我们采用甲基化特异性PCR和免疫组化的方法对异型增生 (2 3例 )、早期胃癌 (2 0例 )和进展期胃癌 (2 0例 )石蜡标本进行启动子甲基化状态及蛋白表达的分析。结果表明E cadherin基因启动子在异型增生、早期胃癌和进展期胃癌中均有甲基化 ,其阳性率分别为78 3% ,80 %和 90 % ,经χ2 检验各病例组与正常组 (30 % )比较均有差异 (P <0 0 5 ) ,但各病例组间没有差异 (P >0 0 5 ) ;进展期胃癌E cadherin蛋白表达全部阴性 ,早期胃癌 70 %阴性 ,异型增生中无蛋白阴性 ,在早期胃癌和进展期胃癌 34例蛋白表达阴性的标本中 31例有启动子甲基化 (91 2 % ) ,蛋白表达与启动子甲基化呈明显负相关 (P <0 0 1)。表明E cadherin启动子甲基化是胃癌发生的早期事件 ,也是胃癌发生、进展的重要事件     

毛细管电泳-单链构象多态分析检测胃癌中p16基因突变

目的:建立快速高效检测胃癌患者胃癌组织及癌旁正常组织中p16基因突变的方法。方法:采用PCR扩增p16基因第二外显子易发生突变片段,扩增样品纯化后经95℃变性;以毛细管电泳(CE)分析法结合单链构象多态性(SSCP)对60例胃癌患者p16基因突变情况进行分析。结果:分析结果表明只有3例低分化腺癌患者存在基因突变,测序表明p16基因第二外显子碱基序列AGAC发生碱基A丢失。结论:p16基因突变可能导致胃癌的发生,但不起主导作用;CE-SSCP分析方法具有快速、灵敏、准确的特点,可用于胃癌组织中p16基因的突变分析。     

人乳头瘤病毒16E5突变与宫颈癌的研究进展

人乳头瘤病毒(Humanpapillomavirus)HPV是发生宫颈癌的必要条件,人乳头瘤病毒16E5癌基因突变与宫颈癌的发生有密切的相关性。人乳头瘤病毒E5是一种转化作用的癌蛋白,是细胞膜或内膜整合蛋白。人乳头瘤病毒E5在感染的细胞中表达。主要在感染细胞克隆早期的繁殖,扩张中起重要作用。它干预生长因子受体,干扰周期蛋白和周期蛋白激酶,促进病毒癌基因转化,抑制抑癌基因表达,激活启动子促进病毒繁殖,并通过多种机制促使损伤细胞,通过细胞周期,使宿主细胞增殖,分化延缓,恶性化。E5基因变异意味着功能有可能改变,可能机体或细胞对病毒变异株的免疫能力,与宫颈癌的发生和HPV的嗜上皮性有关,因此对人乳头瘤病毒16E5基因变异的研究对于人乳头瘤病毒16在宫颈癌发病中的作用有着不可忽略的意义。本文对人乳头瘤病毒16E5突变株在宫颈癌组织中的作用及其基因突变的研究现状进行分析。     

Clinical Significance of a Point Mutation in DNA Polymerase Beta (POLB) Gene in Gastric Cancer

Gastric cancer (GC) is a major cause of global cancer mortality. Genetic variations in DNA repair genes can modulate DNA repair capability and, consequently, have been associated with risk of developing cancer. We have previously identified a T to C point mutation at nucleotide 889 (T889C) in DNA polymerase beta (POLB) gene, a key enzyme involved in base excision repair in primary GCs. The purpose of this study was to evaluate the mutation and expression of POLB in a larger cohort and to identify possible prognostic roles of the POLB alterations in GC. Primary GC specimens and their matched normal adjacent tissues were collected at the time of surgery. DNA, RNA and protein samples were isolated from GC specimens and cell lines. Mutations were detected by PCR-RFLP/DHPLC and sequencing analysis. POLB gene expression was examined by RT-PCR, tissue microarray, Western blotting and immunofluorescence assays. The function of the mutation was evaluated by chemosensitivity, MTT, Transwell matrigel invasion and host cell reactivation assays. The T889C mutation was detected in 18 (10.17%) of 177 GC patients. And the T889C mutation was associated with POLB overexpression, lymph nodes metastases and poor tumor differentiation. In addition, patients with- the mutation had significantly shorter survival time than those without-, following postoperative chemotherapy. Furthermore, cell lines with T889C mutation in POLB gene were more resistant to the treatment of 5-fluorouracil, cisplatin and epirubicin than those with wild type POLB. Forced expression of POLB gene with T889C mutation resulted in enhanced cell proliferation, invasion and resistance to anticancer drugs, along with increased DNA repair capability. These results suggest that POLB gene with T889C mutation in surgically resected primary gastric tissues may be clinically useful for predicting responsiveness to chemotherapy in patients with GC. The POLB gene alteration may serve as a prognostic biomarker for GC.     

Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer

TNM stage still serves as the best prognostic marker in gastric cancer (GC). The next step is to find prognostic biomarkers that detect subgroups with different prognoses in the same TNM stage. In this study, the expression levels of epidermal growth factor receptor (EGFR) and cyclin D1 were assessed in 96 tissue samples, including non-tumorous tissue, adenoma, and carcinoma. Then, the prognostic impact of EGFR and cyclin D1 was retrospectively investigated in 316 patients who underwent R0 resection for GC. EGFR positivity increased as gastric tissue became malignant, and cyclin D1 positivity was increased in all the tumorous tissues. However, there was no survival difference caused by the EGFR positivity, while the cyclin D1-postive group had worse overall survival (OS) than the cyclin D1-negative group in stage I GC (10-year survival rate (10-YSR): 62.8% vs. 86.5%, p = 0.010). In subgroup analyses for the propensity score-matched (PSM) cohort, there were also significant differences in the OS according to the cyclin D1 positivity in stage I GC but not in stage II and III GC. Upon multivariate analysis, cyclin D1 positivity was an independent prognostic factor in stage I GC. In conclusion, cyclin D1 may be a useful biomarker for predicting prognosis in stage I GC.     

抗胃癌单抗3H11可变区氨基端序列对抗体活性的影响

采用RT-PCR方法,利用第一骨架区通用引物扩增重链Fd段和κ链的基因,克隆到Fab表达载体中,在大肠杆菌中获得了表达但未检测到抗原结合活性.根据已克隆的3H11 VL、VH的真实序列,重新设计κ链及Fd段5′端引物,分别将骨架区引物在κ链及Fd段5′端所造成的氨基酸残基改变纠正为原始序列,构建分别含有矫正后κ链或矫正后Fd以及二个链均得到矫正的Fab表达载体,这些载体在大肠杆菌中均获得类似水平的表达,对任何一个链的矫正均可部分恢复Fab段胃癌细胞的结合活性.结果说明在构建小分子抗体时,PCR引物引入的轻、重链可变区氨基端氨基酸残基的改变可严重影响所表达抗体的抗原结合活性.     

中国人胃癌KAI1基因表达及遗传不稳定性

采用Envision免疫组织化学,Leica-Qwin计算机图像分析,石蜡包埋组织抽提DNA,PCR-单链构象多态性(SSCP)和常规银染等方法,对56例石蜡包埋胃癌标本及其相应的正常组织,进行KAI1蛋白表达水平的研究和D1S1344、D11S1326位点微卫星不稳定(MSI)、杂合性缺失(LOH)的检测,为揭示KAI1基因作用机制和肿瘤转移机制提供实验依据。实验中,胃癌KAI1蛋白阳性检出率为55.4%(31/56):随着癌组织浸润程度的进展,其阳性率呈降低趋势(P<0.01);在无淋巴结转移的肿瘤组织KAI1蛋白表达率为83.9%,显著高于淋巴结转移肿瘤组织的20.0%;在肿瘤结节转移(tumor node metastasis,TNM)Ⅰ Ⅱ期,KAI1蛋白阳性率为82.8%,明显高于TNMⅢ Ⅳ期的25.9%(P<0.01)。56例胃癌D11S1326、D11S1344位点的SSCP分析中,均未出现MSI或LOH。实验结果提示,KAI1蛋白表达与胃癌组织浸润、淋巴结转移及恶性进展密切相关。在胃癌的发生发展中,KAI1基因未见遗传不稳定性改变。